Altria's Smokeable Segment Shrinks: Is it Time to Pivot Faster?

Altria (MO) is facing pressure as its Q1 2025 smokeable segment saw a 13.7% drop in cigarette volumes and a 5.8% revenue decline to $4.62 billion, driven by economic pressures, a shift to discount brands, and the rise of illicit e-vapor products which now dominate over 60% of the e-vapor market. While Altria has invested in smoke-free alternatives, the decline in smokeable sales suggests the need to accelerate this transition; competitors Philip Morris International and British American Tobacco are also facing combustible volume declines and are focusing on smoke-free products.

Analysis

Altria Group (MO) is experiencing significant headwinds in its traditional smokeable products segment, evidenced by a 13.7% year-over-year decline in domestic cigarette shipment volumes and a 5.8% drop in smokeable segment net revenues to $4.62 billion in Q1 2025, contributing to a 5.7% decrease in total company revenues. These declines are driven by economic strain on consumers, a shift towards discount brands which gained 1.8 share points while Altria's flagship Marlboro brand lost 1 share point, and the rapid growth of illicit e-vapor products now comprising over 60% of that market. This situation intensifies the need for Altria to expedite its transition to smoke-free alternatives such as NJOY and on!. Competitors like Philip Morris International (PM) and British American Tobacco (BTI) are also grappling with shrinking combustible volumes—PM saw a 1.3% Q1 2025 global cigarette industry volume drop and expects a low single-digit full-year decline, while BTI is aggressively pursuing reduced-risk products (RRPs) with ambitious long-term targets, aiming for 50% of total revenues from RRPs by 2035. Notably, PM's smoke-free products boast gross profit margins over five percentage points higher than combustibles. Year-to-date, Altria's shares have gained 12%, underperforming the industry's 38.3% growth, and the stock trades at a forward price-to-earnings ratio of 10.73X, below the industry average of 15.47X. Despite these challenges, consensus earnings estimates for MO project 5.3% growth in 2025 and 3% in 2026.

Key Decisions for Investors

• Investors should critically evaluate Altria's progress and speed in its smoke-free transition, as the rapid decline in its core smokeable segment revenues (down 5.8% in Q1 2025) and volumes (down 13.7%) creates significant urgency for successful diversification.
• Careful consideration should be given to Altria's valuation (forward P/E of 10.73X) and projected earnings growth (5.3% for 2025, 3% for 2026) relative to the substantial structural headwinds, its stock's 12% YTD gain significantly lagging the industry's 38.3%, and the pace of its strategic pivot compared to competitors.
• Regulatory developments impacting illicit e-vapor products and the competitive intensity in the smoke-free market are key factors to monitor, as they will directly affect Altria's ability to stabilize revenues and capture growth in new categories.